Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VESELL ES")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 74

  • Page / 3
Export

Selection :

  • and

ELUCIDATION OF THE PHARMACOKINETIC INTERACTION BETWEEN ACUTELY ADMINISTERED ETHANOL AND BENZODIAZEPINESVESELL ES.1980; J. LAB. CLIN. MED.; USA; DA. 1980; VOL. 95; NO 3; PP. 305-309; BIBL. 14 REF.Article

THE ANTIPYRINE TEST IN CLINICAL PHARMACOLOGY: CONCEPTIONS AND MISCONCEPTIONSVESELL ES.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 26; NO 3; PP. 275-286; BIBL. 92 REF.Article

PHARMACOGENETICSVESELL ES.1975; BIOCHEM. PHARMACOL.; G.B.; DA. 1975; VOL. 24; NO 4; PP. 445-450; BIBL. 62 REF.Article

ON THE SIGNIFICANCE OF HOST FACTORS THAT AFFECT DRUG DISPOSITIONVESELL ES.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 1; PP. 1-7; BIBL. 13 REF.Article

GENETIC AND ENVIRONMENTAL FACTORS AFFECTING DRUG RESPONSE IN MAN = FACTEURS GENETIQUES ET ENVIRONNANTS AFFECTANT LA REPONSE AUX MEDICAMENTS CHEZ L'HOMMEVESELL ES.1972; FEDER. PROC.; U.S.A.; DA. 1972; VOL. 31; NO 4; PP. 1253-1269; BIBL. 59REF.Serial Issue

GENETIC AND ENVIRONMENTAL FACTORS AFFECTING DRUG METABOLISM IN MAN = FACTEURS GENETIQUES ET FACTEURS DE L'ENVIRONNEMENT AFFECTANT LE METABOLISME DES MEDICAMENTS CHEZ L'HOMMEVESELL ES.1973; EXCERPTA MED., INTERNATION. CONGR. SER.; PAYS-BAS; DA. 1973; NO 250; PP. 391-414; BIBL. 2REF.; (C.R. IVE CONGR. INT. GENET. HUM.; PARIS; 1971)Conference Paper

ADVANCES IN PHARMACOGENETICSVESELL ES.1973; PROGR. MED. GENET.; U.S.A.; DA. 1973; VOL. 9; PP. 291-367; BIBL. 12P.1/2Serial Issue

POLYGENIC FACTORS CONTROLLING DRUG RESPONSE = FACTEURS POLYGENIQUE CONTROLANT LA REPONSE AUX MEDICAMENTSVESELL ES.1974; MED. CLIN. N. AMER.; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 951-963; BIBL. 36REF.Article

DRUG THERAPY: PHARMACOGENETICSVESELL ES.1972; NEW ENGL. J. MED.; U.S.A.; DA. 1972; VOL. 287; NO 18; PP. 904-909; BIBL. 28REF.Serial Issue

NORMAL ANTIPYRINE METABOLISM IN PATIENTS WITH CHOLESTEROL CHOLELITHIASIS. EVIDENCE THAT THE DISEASE IS NOT DUE TO GENERALIZED HEPATIC MICROSOMAL DYSFUNCTION = METABOLISME NORMAL DE L'ANTIPYRINE CHEZ LES SUJETS AYANT UNE CHOLELITHIASE AU CHOLESTEROL . PREUVE QUE CETTE MALADIE N'EST PAS DUE A UN DYSFONCTIONNEMENT GENERALISE DES MICROSOMES HEPATIQUESHEPNER GW; VESELL ES.1975; AMER. J. DIGEST. DIS.; U.S.A.; DA. 1975; VOL. 20; NO 1; PP. 9-12; BIBL. 20REF.Article

QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION BY BREATH ANALYSIS AFTER ORAL ADMINISTRATION OF (14C) AMINOPYRINE = EVALUATION QUANTITATIVE DE LA FONCTION HEPATIQUE PAR L'ANALYSE DE LA RESPIRATION APRES ADMINISTRATION ORALE D'AMINOPYRINE-14CHEPNER GW; VESELL ES.1975; ANN. INTERN. MED.; U.S.A.; DA. 1975; VOL. 83; NO 5; PP. 632-638; BIBL. 49 REF.Article

UNALTERED METABOLISM OF ANTIPYRINE AND TOLBUTAMIDE IN FASTING MANREIDENBERG MM; VESELL ES.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 17; NO 6; PP. 650-656; BIBL. 23REF.Article

ENHANCED DRUG-METABOLIZING CAPACITY WITHIN LIVER ADJACENT TO HUMAN AND RAT LIVER TUMORSSULTATOS LG; VESELL ES.1980; PROC. NATION. ACAD. SCI.; USA; DA. 1980; VOL. 77; NO 1 PART. 1; PP. 600-603; BIBL. 18 REF.Article

ANOMALOUS RESULTS OF STUDIES ON DRUG INTERACTION IN MAN. II. HALOFENATE (MK-185) AND ANTIPYRINE, BISHYDROXYCOUMARIN, AND WARFARINVESELL ES; PASSANANTI GT.1975; PHARMACOLOGY; SWITZ.; DA. 1975; VOL. 13; NO 2; PP. 112-127; BIBL. 12REF.Article

AMINOPYRINE METABOLISM IN THE PRESENCE OF HYPERBILIRUBINEMIA DUE TO CHOLESTASIS OR HEPATOCELLULAR DISEASE. COMBINED USE OF LABORATORY TESTS TO STUDY DISEASE-INDUCED ALTERATIONS IN DRUG DISPOSITION.HEPNER GW; VESELL ES.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 21; NO 5; PP. 620-626; BIBL. 1 P. 1/2Article

TEMPORAL VARIATIONS IN ACETAMINOPHEN AND PHENACETIN HALF-LIFE IN MAN.SHIVELY CA; VESELL ES.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 4; PP. 413-424; BIBL. 20 REF.Article

TRAINING PROGRAMS IN CLINICAL PHARMACOLOGYSPECTOR R; VESELL ES.1980; J. CLIN. PHARMACOL.; USA; DA. 1980; VOL. 20; NO 5-6 PART. 1; PP. 309-315; BIBL. 10 REF.Article

INTERACTION BETWEEN SULINDAC AND WARFARIN: DIFFERENT RESULTS IN NORMAL SUBJECTS AND IN AN UNUSUAL PATIENT WITH A POTASSIUM-LOSING RENAL TUBULAR DEFECTLOFTIN JP; VESELL ES.1979; J. CLIN. PHARMACOL.; USA; DA. 1979; VOL. 19; NO 11-12; PP. 733-742; BIBL. 11 REF.Article

PHARMACOKINETIC INTERPRETATION OF DATA GATHERED DURING THERAPEUTIC DRUG MONITORING.DVORCHIK BH; VESELL ES.1976; CLIN. CHEM.; U.S.A.; DA. 1976; VOL. 22; NO 6; PP. 868-878; BIBL. 1 P. 1/2Article

COMPARATIVE STIMULATORY EFFECTS OF FOUR PHENOTHIAZINES ON HEPATIC MICROSOMAL ENZYMESAURORI KC; VESELL ES.1974; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1974; VOL. 2; NO 6; PP. 566-572; BIBL. 30REF.Article

INHIBITION OF THEOPHYLLINE METABOLISM BY LONG-TERM ALLOPURINOL ADMINISTRATIONMANFREDI RL; VESELL ES.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 29; NO 2; PP. 224-229; BIBL. 17 REF.Article

AMINOPYRINE DISPOSITION: STUDIES ON BREATH, SALIVA, AND URINE OF NORMAL SUBJECTS AND PATIENTS WITH LIVER DISEASE.HEPNER GW; VESELL ES.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 20; NO 6; PP. 654-660; BIBL. 14 REF.Article

LIQUID CHROMATOGRAPHIC ASSAY OF WARFARIN: SIMILARITY OF WARFARIN HALF-LIVES IN HUMAN SUBJECTSVESELL ES; SHIVELY CA.1974; SCIENCE; U.S.A.; DA. 1974; VOL. 184; NO 4135; PP. 466-468; BIBL. 13REF.Article

ASSESSMENT OF AMINOPYRINE METABOLISM IN MAN BY BREATH ANALYSIS AFTER ORAL ADMINISTRATION OF 14C-AMINOPYRINE. EFFECTS OF PHENOBARBITAL, DISULFIRAM AND PORTAL CIRRHOSIS = EVALUATION DU METABOLISME DE L'AMINOPYRINE CHEZ L'HOMME PAR L'ANALYSE DE LA RESPIRATION APRES ADMINISTRATION ORALE D'AMINOPYRINE-14C. EFFETS DU PHENOBARBITAL, DU DISULFIRAM ET DE LA CIRRHOSE PORTALEHEPNER GW; VESELL ES.1974; NEW ENGL. J. MED.; U.S.A.; DA. 1974; VOL. 291; NO 26; PP. 1384-1388; BIBL. 34REF.Article

SIGNIFICANCE OF ERROR ASSOCIATED WITH USE OF THE ONE-COMPARTMENT FORMULA TO CALCULATE CLEARANCE OF THIRTY-EIGHT DRUGS.DVORCHIK BK; VESELL ES.1978; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1978; VOL. 23; NO 6; PP. 617-623; BIBL. 41 REF.Article

  • Page / 3